Renovo clinical trials
The registry lists 30 studies whose lead sponsor is Renovo. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 3, 2011.
Our grouping of 1 registry name, not the registry’s. See them and correct one ↓
- 30studies on the registry
- 0open to participants now
What it is testing
The drugs Renovo’s studies test, most studies first; none is open now — 3 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
- TGFB3 protein, human1 in phase 30 open · 18
- 0 open · 3
- Estradiol1 in phase 30 open · 2
All 30 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 07
- 408
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 19 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Renovo.
- Renovo30 studiesSame company
Something wrong?
Focus areas
Conditions Renovo leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 30 of 30.
- Juvista in Scar Revision Surgery of Disfiguring ScarsCompletedNCT00742443Phase 3
- Prevascar in African Continental Group ScarringStatus unknownNCT01115868Phase 1
- Adaprev in Digital Flexor Tendon RepairStatus unknownNCT01014494Not applicable
- A Trial to Compare the Efficacy of Two Formulations of Avotermin Against PlaceboCompletedNCT01029158Phase 1
- Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe KeloidsCompletedNCT00836147Phase 1/2
- Juvista (Avotermin) in Scars Following Varicose Vein RemovalCompletedNCT00430326Phase 2
- Juvista in the Non-surgical Improvement of Existing ScarsWithdrawnNCT00821457Not applicable
- Safety of Juvista When Administered Following Excision of Ear Lobe KeloidsCompletedNCT00710333Phase 1/2
- Investigation of the Efficacy of Zesteem in Accelerating Early Wound HealingCompletedNCT00984386Phase 2
- Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three TimesCompletedNCT00984516Phase 2
- Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)CompletedNCT00984646Phase 2
- Safety and Efficacy Study of Avotermin (Juvista) in Female SubjectsCompletedNCT00984581Phase 1/2
- Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor SitesCompletedNCT00984503Phase 2
- Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy SubjectsCompletedNCT00984854Phase 1
- Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)CompletedNCT00978367Phase 1/2
- Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid ScarsCompletedNCT00469235Phase 1/2
- Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)CompletedNCT00978302Phase 1
- Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male SubjectsCompletedNCT00977951Phase 1/2
- Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor SitesCompletedNCT00426972Phase 3
- Safety and Efficacy of RN1001(Avotermin) in Healthy Male SubjectsCompletedNCT00847925Phase 1/2
- Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.CompletedNCT00847795Phase 1/2
- Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.Status unknownNCT00432211Phase 2
- Juvista (Avotermin) in Breast Reduction Surgery ScarsTerminatedNCT00432328Phase 2
- Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082CompletedNCT00663780
- Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor SitesCompletedNCT00664352Phase 1/2
- RN1001(Avotermin) in Scar Improvement Following Breast AugmentationCompletedNCT00436449Phase 2
- A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi ExcisionStatus unknownNCT00656227Phase 2
- Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and WomenCompletedNCT00629811Phase 2
- Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin IncisionsCompletedNCT00627536Phase 2
- Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy MalesCompletedNCT00594581Phase 2